Progress and clinical application of sentinel lymph node biopsy technique in gynecological malignant tumors
10.3760/cma.j.cn112152-20240924-00411
- VernacularTitle:妇科恶性肿瘤前哨淋巴结活检技术的研究进展与临床应用
- Author:
Jingwen GAN
1
;
Dongyan CAO
1
Author Information
1. 国家妇产疾病临床医学研究中心 中国医学科学院北京协和医学院北京协和医院妇产科，北京100730
- Publication Type:Journal Article
- Keywords:
Vulvar neoplasms;
Cervical neoplasms;
Endometrial neoplasms;
Sentinel lymph nodebiopsy
- From:
Chinese Journal of Oncology
2025;47(8):689-695
- CountryChina
- Language:Chinese
-
Abstract:
The sentinel lymph node (SLN) is the first group of lymph nodes involved in cancer metastasis. SLN biopsy (SLNB) refers to the positioning and biopsy of the SLNs in the operation using specific tracers to assess the status of lymph node metastasis. It has attracted increasing attention and has been applied in gynecological malignant tumors due to its less invasiveness, fewer complications, and high diagnostic rate. However, it also has produced a series of problems to be explored and solved. This review introduces the existing tracer methods, and discusses the indications of application and the clinical trials of SLNB in vulvar cancer, cervical cancer, and endometrial cancer in order to provide reference for the rational application of SLNB in gynecological malignant tumors.
